|
|
||||||||
1 From the Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, St. Louis, Missouri; 3 Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison; and 2 Departments of Immunology and Ophthalmology, Universidade Federal de Uberlandia, Uberlandia, Brazil.
| Abstract |
|---|
|
|
|---|
METHODS. Unilateral, chronic elevated IOP was induced in 11 rhesus monkeys by laser scarification of the trabecular meshwork. IOP was monitored weekly and maintained within 25 to 45 mm Hg for 7 to 36 weeks. In 6 monkeys, unilateral, optic nerve transection was performed, and monkeys were killed after 4 weeks. Optic nerve damage was assessed by stereoscopic slit-lamp biomicroscopy and fundus photography and by confocal scanning laser ophthalmoscopy. The eyes were enucleated and processed for immunohistochemistry and in situ hybridization and for electron microscopic immunogold detection of elastin. Axonal loss was evaluated in cross sections of the optic nerve stained with phenylenediamine.
RESULTS. Compared with normal contralateral controls, the lamina cribrosa of eyes with elevated IOP exhibited markedly increased elastin and the presence of elastotic aggregates in the extracellular matrix and upregulation of elastin mRNA in the astrocytes. In transected eyes, elastin appeared as fine fibers in the lamina cribrosa, without elastotic aggregates, and without new synthesis or abnormal deposition of elastin. At the transected site, new synthesis of elastin was present in the pia mater but not in astrocytes in the glial scar.
CONCLUSIONS. This study demonstrates that abnormal elastin synthesis in experimental glaucomatous optic neuropathy in the monkey is specific to elevated IOP and not secondary to axonal loss. The mechanisms by which elevated IOP induces enhanced elastin synthesis in laminar astrocytes are unknown but differ from those involved in acute axonal injury such as transection, where inflammation and breakdown of the bloodnerve barrier occur.
| Introduction |
|---|
|
|
|---|
There is substantial evidence that damage to the optic nerve axons occurs at the level of the lamina cribrosa in the optic nerve head (for comprehensive reviews, see Refs. 5 6 7 8 9 ). In the glaucomatous optic nerve, cupping of the optic disc and compression, stretching, and rearrangement of the cribriform plates of the lamina cribrosa occur in response to elevated IOP.1 Remodeling of the optic nerve head in glaucoma involves astrocyte responses and changes in the extracellular matrix (ECM) composition and distribution.10 11 12 13 14 15 16 17 18 19 20 21 22
Elastic fibers are a major component of the ECM of the lamina cribrosa of humans and nonhuman primates as demonstrated previously by our laboratory and by others.2 Elastic fibers provide the lamina with elasticity and resiliency to adapt to changes in IOP. Elastic fibers are composed of an amorphous core containing elastin, an insoluble polymer of 70 kDa, tropoelastin monomers, and a microfibrillar component, located primarily around the periphery and interspersed within the amorphous core. Elastin is secreted by elastogenic cells as tropoelastin, a soluble precursor, which is assembled into insoluble elastin by cross-linking in the extracellular space.3
Type 1B astrocytes are the major cell type in the human optic nerve head and are responsible for the synthesis of ECM macromolecules in the lamina cribrosa.4 5 6 Type 1B astrocytes express elastin perinatally and in early childhood, but elastin mRNA is not detectable in normal adult optic nerve heads by in situ hybridization (ISH) or by RT-PCR.7 8 In glaucomatous optic neuropathy, expression of elastin mRNA reappears, and abnormal deposition of elastin and elastosis follows.7 8 9 Elastotic degeneration of the ECM of the lamina cribrosa in glaucoma is characterized by a significant increase in the area occupied by elastin, which is organized in large amorphous aggregates of irregular and varied shapes.7 9 10 Elastic fiber degeneration or elastosis is apparent in early stages of POAG, with evidence of redistribution and disorganization of the elastic component, accompanied by upregulation of tropoelastin mRNA expression. These changes in elastic fibers may contribute to the changes in compliance and resiliency observed in the glaucomatous lamina cribrosa.11 12 13
After any type of insult to the central nervous system, astrocytes exhibit a vigorous response, specific to the region or to the nature of the insult involved, and become reactive.14 In the optic nerve head, mature astrocytes become reactive in response to elevated IOP. Reactive astrocytes exhibit a characteristic phenotype and actively synthesize a variety of molecules in response to stress.15 Reactive astrocytes adopt many of the properties of immature astrocytes, such as motility and expression of developmentally regulated molecules, for instance, NCAM-180 and elastin in the case of glaucoma.6 16 In addition to participating in the remodeling of the ECM, reactive astrocytes also synthesize cytokines and mediators that are highly neurotoxic for RGCs.14 17 18
It has been suggested that the neurodegeneration that follows optic nerve transection has similarities to glaucomatous optic nerve degeneration, and thus optic nerve crush and/or transection animal models have been used to develop strategies for neuroprotection in glaucoma.19 20 Elevated IOP is the most prominent risk factor in the development and progression of glaucoma, yet the mechanisms by which IOP damages the optic nerve head remain unknown. It is possible that the molecular mechanisms responsible for remodeling of the ECM in the optic nerve head are specific to mechanical stress associated with elevated IOP in glaucoma and not a secondary event due to loss of axons.
We designed this study to compare the expression of elastin, a marker of ECM remodeling in the glaucomatous ONH, in monkeys with laser-induced experimental glaucoma and in monkeys with optic nerve transection. To detect qualitative and quantitative changes in synthesis and deposition of elastin by type 1B astrocytes, we used immunohistochemistry at the light and electron microscopic level. To determine whether new elastin is synthesized in the ONH, we used ISH for detection and localization of elastin mRNA to specific cell types.
| Materials and Methods |
|---|
|
|
|---|
Ten animals had experimental glaucoma (referred to as experimental
glaucoma group [ExpG]) induced in one eye by argon laser
scarification of the trabecular meshwork (ALTS).21
22
23
24
A
standard clinical argon laser (model 900; Coherent Radiation, Palo
Alto, CA) and slit-lamp delivery system was used to produce 50 to 250
spots of 50-µm spot diameter, 1 to 1.5 W energy, and 0.5-second
duration, over 270° of the angle circumference. This procedure was
repeated at approximately 3- to 4-week intervals, when ocular
inflammation had subsided, each time leaving a different quadrant
untreated, until an elevation in IOP was achieved. In no case did IOP
decrease, requiring additional ALTS, once it became elevated. One
additional animal (11) did not undergo laser surgery but developed
elevated IOP after an intracapsular lens extraction procedure as part
of another protocol. In this animal, the vitreous in the ExpG eye moved
forward, possibly blocking the anterior chamber angle, and
biomicroscopic evidence of inflammation (anterior chamber cells and
flare) was present for 1 or 2 weeks postoperatively. Anesthesia for
lasering was ketamine (10 mg/kg IM) + acepromazine (0.21 mg/kg IM).
Frequently the animals also received IM methohexital anesthesia, if
photography and scanning laser ophthalmoscopy was done immediately
before laser treatment (see below). In five of these animals, IOP was
maintained at
40 to 50 mm Hg for 8 to 12 weeks, whereas in the other
four animals IOP was kept at
20 to 30 mm Hg for 27 to 36 weeks. If
IOP was higher than desired, the monkeys were treated topically once or
twice daily with a single drop of one or more of the following until
the desired IOP was achieved: Timoptic-XE (0.5% timolol maleate in
gel-forming vehicle; Merck & Co, West Point, PA), Alphagan (0.2%
brimonidine tartrate; Allergan, Irvine, CA), Trusopt (2% dorzolamide
hydrochloride; Merck), PGF2
-1-isopropylester (2 µg in 5 µl
saline; donated by Pharmacia Corp, Pepack, NJ). If necessary,
acetazolamide (5 mg/kg, Ben Venue Laboratories, Bedford, OH) IM was
also given once or twice daily.
Monkey 14 had the IOP in the lasered eye reduced to control levels with
Timoptic, Alphagan, Trusopt, and PGF2
-1-isopropylester 1 week before
being killed to determine whether cupping was due to a permanent
structural change or merely a consequence of elevated IOP.
Six animals underwent transection of the optic nerve (ONT) in one eye, preserving the central vessels as verified by the absence of hemorrhage by indirect ophthalmoscopy at the completion of the transection and again several days later.25 Briefly, an oculoplastic surgeon performed a lateral orbitotomy under pentobarbital anesthesia (15 mg/kg IV or 35 mg/kg IM). The intraconal space was entered by gentle dissection between the lateral and superior recti muscles, under 2.5x-loupe magnification. A malleable retractor was used to gently retract the globe medially. At all times pressure on the globe was kept as light as possible, and pressure was released for a few seconds every 2 to 3 minutes. Under visualization with an operating microscope, the optic nerve was exposed, and a sickle knife was used to make a 3-mm linear incision in the dura parallel to the nerve, as far posteriorly as practical (at least 15 mm posterior to the globe) to avoid damage to the central retinal artery. Dural vessels and use of cautery were avoided. Neurosurgical angled fine scissors were then used to extend the incision posteriorly several millimeters. The scissors were then inserted within the dural sheath, and the nerve transected (2 cuts each, two thirds through the nerve) under direct visualization. The retina was then observed by direct and indirect ophthalmoscopy, to ensure that no central retinal artery occlusion occurred. The wounds were closed, and the animals treated with systemic benzathine and procaine penicillin (30,000 U/kg; Phoenix Pharmaceutical, Inc., St. Joseph, MO) for 5 days and systemic methylprednisolone acetate (Depo-Medrol, 1 mg/kg IM; Pharmacia Corp., Pepack, NJ) for 3 weeks, tapering to 0.1 mg/kg for 1 more week until killing. The ONT monkeys were followed for 4 weeks by slit-lamp biomicroscopic examination of the anterior and posterior segments and indirect ophthalmoscopy of the posterior segment and then killed.
In all animals IOP was measured under ketamine anesthesia with a
minified Goldmann (Haag-Streit, Köniz, Switzerland) applanation
tonometer,26
occasionally backed up by measurements with a
Tono-pen XL (Mentor O&O, Norwell, MA) if corneal edema or
neovascularization, or head and eye movements under ketamine anesthesia
prevented readings with the Goldmann.27
The IOP was
measured before ALTS or ONT and then weekly thereafter, with the monkey
lying prone in a head holder and with the head
4 cm above the heart.
Stereoscopic fundus photographic (Topcon TRC 50IA fundus camera; Topcon America Corporation, Paramus, NJ) and confocal scanning laser ophthalmoscopic (TopSS Topographic Scanning System; Laser Diagnostic Technologies, Inc., San Diego, CA) images were obtained in all animals before ALTS or ONT and before killing, and in some cases also at intermediate times during the period of pressure elevation. Pupils were dilated with 2.5% phenylephrine HCl (Mydfrin; Alcon, Ft. Worth, TX) and 1% tropicamide (Mydriacyl; Alcon). Anesthesia for these procedures was ketamine (10 mg/kg, IM) + acepromazine (0.21 mg/kg IM), + methohexital sodium (15 mg/kg, IM) if needed to eliminate eye movements.
A summary of the clinical data on the animals is shown in Table 1 .
|
100 µl of vitreous from each eye.
After induction with IM ketamine (10 mg/kg), the monkeys were placed
under deep pentobarbital anesthesia (35 mg/kg IM or 15 mg/kg IV), and
the pupils were dilated with phenylephrine and tropicamide. A 23-gauge
needle was inserted through the pars plana 12 to 4 mm toward the
papillo-macular nerve fiber bundle under direct visualization with an
operating microscope. By using ocular geometry, we estimate the needle
tip to have been
4 mm from the retinal surface. The vitreous sample
was quickly frozen in liquid nitrogen for future biochemical assay, in
conjunction with samples from other animals from other protocols, to be
reported elsewhere), and the vitreous cavity volume was restored with
Na-hyaluronate (Healon, Pharmacia). The monkeys were then perfused
through the heart with 4% paraformaldehyde in 0.1 M phosphate-buffered
saline (PBS; pH 7.4). After enucleation the eyes were immersed in 4%
paraformaldehyde for 12 to 24 hours, after which optic nerve heads were
dissected free from sclera and surrounding tissues. Samples for
electron microscopy were postfixed in 0.5% glutaraldehyde/2%
paraformaldehyde for 1 hour and processed for embedding in LR White
resin (Electron Microscopy Sciences, Fort Washington, PA).
Samples for light microscopy and ISH were extensively washed in 0.2%
glycine in PBS and processed for paraffin embedding. Slides for ISH
were handled using sterile techniques to avoid RNase contamination of
the sections. Samples of myelinated nerve for evaluation of axonal
damage were osmicated and embedded in epoxy resin.
Electron Microscopy and Image Analysis
After embedding, ultrathin random sections were made of the
lamina cribrosa and placed onto nickel grids, as previously
described.7
9
For immunogold localization of elastin,
grids were first blocked with 5% nonfat milk and then with an
antiserum against human aortic
-elastin (work dilution 1:100;
Elastin Products, Owensville, MO). Colloidal gold-labeled IgG (Jansen
Biotech, Olen, Belgium) was diluted 1:12 in 0.05 M Tris buffer
containing 1.5% bovine serum albumin (BSA), pH 8.3. All specimens were
counterstained with uranyl acetate and lead citrate and examined with a
Zeiss EM 902A electron microscope (Oberkochen, Germany).
Sagittal sections taken from the lamina cribrosa were examined, and areas of ECM containing cross-sectioned elastic and collagen fibers were examined. Twelve micrographs randomly taken from the lamina cribrosa at 26000x magnification from each eye were scanned with a HP ScanJet 4c (Hewlett-Packard, Palo Alto, CA) connected to a PC computer. Using Optimas image analysis software (Bothel, WA) gold grains were counted per 46.35-µm2 area and plotted for statistical analysis. A code number given by the electron microscope identified the photographs so that the investigator performing the measurements did not know which eye, control or experimental, and to which group each animal belonged. The coded photographs were given to the investigator in random order as the electron microscopy technician printed them.
Statistical Analysis
Statistical evaluations were performed at the Biostatistics Core
Module of the Department of Ophthalmology and Visual Sciences,
Washington University. To standardize the elastin count between
monkeys, the elastin count of the experimental eye was expressed as a
fraction of the elastin count in the control eye of the same monkey.
Descriptive statistics were computed for the elastin count of ONT and
ExpG experimental and control eyes and their respective elastin ratios.
To determine whether the mean elastin ratio of the ONT eyes was
different from the mean elastin ratio of ExpG eyes, we performed a
repeated-measures analysis of variance using SAS software (Cary, NC).
The repeated-measures analysis was designed to assess the effects of
using different methods to induce axonal degeneration (ONT vs. ExpG),
using multiple measurements, and the possible interaction of methods
for inducing axonal degeneration with multiple measurements. A
significant interaction would indicate a difference between the ONT and
ExpG methods in the elastin ratio of samples with high elastin counts
compared with samples with low elastin counts.
Evaluation of Nerve Damage
To evaluate optic nerve damage in both ExpG and ONT groups,
cross sections were taken from the myelinated optic nerves and stained
with p-phenylenediamine.28
29
Digital images
were taken with at 2x magnification, so that the entire circumference
of the nerve was within the lens field. Images were imported into
Optimas software, where the total circumference area as well as the
areas with axonal degeneration was measured. Results were expressed as
a ratio between area of axon degeneration and total area. "Mild"
axon loss was defined as a loss of up to one third of myelinated axon
area, "moderate" axon loss when there was loss between one and two
thirds of myelinated axon area, and "marked" axon loss when the
loss in axon area surpassed two thirds of the total myelinated
area.9
Light Microscopy Immunohistochemistry
Antibodies.
A rabbit polyclonal antibody anti-human aortic
-elastin (Elastin
Products), at 1:50 dilution, and a mouse monoclonal antibody anti-human
glial fibrillary acidic protein (GFAP; Sigma Chemical Co., St Louis,
MO), at 1:400 dilution were used for double immunofluorescence.
Rhodamine-Redlabeled goat anti-rabbit IgG and Oregon-Greenlabeled
goat anti-mouse IgG were obtained from Molecular Probes (Eugene, OR).
Immunofluorescence Staining.
Sections (6 µm) were deparaffinized using xylenes and rehydrated
ethanol (100%, 90%, and 70%). To reduce unspecific labeling,
sections were preincubated in Tris-glycine buffer (0.1 M glycine,
brought to pH 7.4 using 1 M Tris buffer) for 30 minutes and washed
twice in PBS, 5 minutes each. Sections were then incubated for 30
minutes in 10% nonimmune calf serum in PBS, followed by incubation
with the primary antibody mixture diluted in 1%BSA/PBS for 30 minutes.
After extensive washes in 1%BSA/PBS, sections were incubated with the
second antibody mixture for another 30 minutes, washed, and mounted
with ProLong medium (Molecular Probes). Negative controls were
performed by replacing the primary antibodies with nonimmune
serum or by incubating sections with inappropriate secondary antibody.
In Situ Hybridization
Probe Preparation.
Antisense and sense riboprobes were prepared from human tropoelastin
clone HDE-1 (gift from Jeffrey Davidson, Vanderbilt University,
Nashville, TN)30
subcloned into a pGEM-3Z vector (Promega,
Madison, WI). Antisense digoxigenin-labeled probe was transcribed by
SP6 RNA polymerase from NdeI-linearized DNA template,
whereas sense digoxigenin-labeled probe was transcribed by T7 RNA
polymerase from HindIII-linearized DNA template. In
vitro transcription was carried out according to the manufacturers
instructions (Dig-RNA labeling system; Roche Molecular Biochemicals,
Indianapolis, IN).
Tissue Preparation and Hybridization.
ISH was carried out as described previously.16
Briefly,
6-µm sagittal sections of monkey ONH and transected optic nerves were
deparaffinized and washed in ethanol. Slides were then incubated for 15
minutes in PBS containing 0.3% Triton X-100, followed by 5 µg/ml
proteinase K (Roche) treatment in PBS for 30 minutes at 37°C. Slides
were fixed in 4% paraformaldehyde, followed by a 0.2% glycine/PBS
wash. Slides were then immersed in freshly prepared 0.5% acetic
anhydride in 0.1 M triethanolamine buffer, pH 8.0, for 10 minutes at
room temperature in a slow shaker. Slides were dehydrated in ethanol
and baked for 30 minutes before addition of probes. Hybridization was
performed in a buffer containing 50% deionized formamide, 2x SSC, 20
mM Tris-HCl, pH 8, 1x Denhardts, 1 mM EDTA, 10% dextran sulfate,
0.5 mg/ml yeast tRNA, and 10 mM DTT. Fifty microliters of hybridization
mixture containing 100 ng of labeled probe was applied to each section
and let to hybridize overnight at 42°C. Slides were washed in 2x SSC
twice for 15 minutes each at 37°C, followed by another wash in RNase
buffer (0.5 M NaCl, 10 mM Tris-HCl, pH 8, 1 mM EDTA) for 15 minutes at
37°C. Slides were treated with 20 µg/ml RNase A (Roche) for 30
minutes at 37°C, followed by washes in 2x, 1x, 0.5x, and 0.1x
SSC, 15 minutes each at 45°C. Slides were rinsed with Tris buffer
(0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl) and blocked with 2% calf serum
in the same buffer for 30 minutes at room temperature. Slides were then
reacted with an alkaline phosphataseconjugated antibody against
digoxigenin (Roche) for 1 hour at 37°C. After washes in Tris buffer,
slides were rinsed in development buffer (0.1 M Tris, pH 9.5, 0.1 M
NaCl, 50 mM MgCl2, 0.1% Tween 20, 5 mM levamisole)
followed by color development with NBT/BCIP solution (Roche) for 3
hours at room temperature. Slides were rinsed in distilled water and
mounted with AquaMount (Fisher Scientific, Piscataway, NJ) without
additional counterstaining.
Visualization and Photography
Slides were examined in a Nikon Optiphot-2 microscope equipped
with epifluorescent illumination (Tokyo, Japan), and images were
recorded using a digital camera (Spot Diagnostic Instruments, Sterling
Heights, MI) and stored as a computer file. Color images of the
blue-stained tissues processed for ISH were converted to grayscale
using Adobe Photoshop 5.0 (Adobe Systems, San Jose, CA).
| Results |
|---|
|
|
|---|
|
The color fundus photographs were not taken with the filters, film, and wide field/low magnification required to optimize visualization of the retinal nerve fiber layer, but rather with the standard white light and color film use for clinical evaluation of the nerve head. Nonetheless, because of the high reflectivity of the nerve fiber layer in the monkey, attenuation of the nerve fiber layer was easily discernible in ocular hypertensive eyes with advanced disc cupping (Fig. 1A vs. 1B; monkey 16) and in the ONT eye with advanced pallor (monkey 4) and was more subtly/equivocally present in several of the other ONT eyes, all compared with their contralateral controls.
At the time the confocal scanning laser ophthalmoscopic images were obtained, the alignment system had not yet been optimized for the anesthetized monkey, which unlike the conscious human subject, cannot fixate on the target light. This made precise quantitative comparison between concurrent experimental and control eye scans or between baseline and postintervention scans difficult. Nonetheless, in some of the glaucomatous and ONT animals, flattening of the papillary/peripapillary superior temporal and inferior temporal "humps" could be seen in the experimental eyes (not shown).
Because the monkey lamina cribrosa is relatively elastic, we believed that it was necessary to demonstrate that mild cupping, such as in monkey 14, was the result of permanent damage and not merely pressure-induced mechanical backward bowing. Observing the nerve head at normal IOP addressed this potential uncertainty. An IOP graph for monkey 14 is shown in Figure 1E . Lowering IOP pharmacologically for 1 week before killing resulted in no change in the surprisingly modest disc cupping (OD C/D = 0.4; OS C/D = 0.2), thus suggesting that there was actual loss of tissue, rather than simply a pressure-induced mechanical backward bowing of the elastic lamina cribrosa. The axonal loss for monkey 14 was also mild (0.28), consistent with the clinical appearance. This procedure was not carried out in hypertensive eyes with clinically obvious advanced cupping, which was borne out histologically, as in monkeys 15 and 16, where the cupping was advanced (0.9) or total (1.0), and the axonal loss ratios were 0.58 and 0.89, respectively, compared with the contralateral eyes.
Evaluation of Nerve Damage
After p-phenylenediamine staining, degenerated axons
stain in dark brownish-red color. The area occupied by degenerated
axons was then measured and expressed as a ratio of the total
cross-sectional area. ExpG eyes had ratios of 0.27 ± 0.02 for
mild damage (n = 3), 0.51 ± 0.05 for moderate
(n = 5), and 0.73 ± 0.08 (n = 3)
for marked axonal loss, respectively. ONT eyes with optic nerve
transection had a ratio of degenerated axons of 0.73 ± 0.05
(n = 6). In most animals there was good correlation
between the clinical findings (Table 1)
and the microscopic evaluation
of axonal loss. However, one monkey (monkey 15 described above),
exhibited a C/D of 0.9 at the time of killing and the axonal loss was
borderline advanced (0.58).
Electron Microscopy
In cross sections of control eyes, elastic fibers were
qualitatively normal, with the characteristic roughly round morphology,
and were embedded in a collagenous matrix (Fig. 2B
), as previously described for human eyes.7
Immunogold
staining using an anti-human elastin antibody positively identified
elastic fibers. In eyes of the ExpG group large confluent elastic fiber
aggregates were observed (Fig. 2A)
, with the same characteristics of
the elastotic degeneration present in the human glaucomatous lamina
cribrosa.9
10
However, no alterations in the morphology of
elastic fibers were found in the lamina cribrosa of eyes from ONT group
(Fig. 2C) compared with contralateral control eyes (Fig. 2D)
, which
showed round elastic fibers throughout the ECM of the lamina cribrosa.
|
|
|
-elastin.
Experimental Glaucoma.
In control eyes elastin staining was localized to the ECM in the
cribriform plates and in blood vessel walls, as described
previously32
(Figs. 3
B, 3D, 3F). In optic nerve heads with mild glaucomatous damage, there
was enhanced immunoreactivity for elastin and some remodeling of the
ECM was observed, as well as few large round astrocytes (reactive
astrocytes) at the edge of the cribriform plates and in the nerve
bundles (Fig. 3A)
. In eyes with moderate glaucomatous damage (Fig. 3C)
there was also enhanced elastin immunoreactivity when compared with
contralateral control eyes (Fig. 3D)
. In addition, there was extensive
remodeling of the ECM with many reactive astrocytes in the nerve
bundles, where there was colocalization of elastin and GFAP staining in
the cytoplasm of astrocytes. In eyes with advanced glaucomatous damage
(Fig. 3E)
there was extensive remodeling of the ECM and compression of
the cribriform plates, with most reactive astrocytes located in the
nerve bundles. There was also enhanced immunoreactivity for elastin
when compared with control contralateral eyes (Fig. 3F)
. No differences
in elastin immunoreactivity were apparent in the distal optic nerve
between eyes with experimental glaucoma and contralateral controls.
Elastic fibers follow longitudinally the pial septa (data not shown).
|
|
|
|
In conclusion, monkeys 11, 13, and 15 without topical treatments exhibited increased elastin deposition and mRNA levels in all eyes with surgically induced elevated IOP, but no new elastin deposition or expression in the contralateral control eyes was detected by immunohistochemistry and ISH. Monkeys 9, 10, 14, 16, and 17 received topical IOP-lowering drugs in the eyes with elevated IOP and exhibited results similar to monkeys 11, 13, and 15. Monkeys with optic nerve transection did not exhibit any differences in elastin deposition or elastin mRNA levels between the transected eye and the contralateral control.
| Discussion |
|---|
|
|
|---|
Elastin is an important component of the ECM of the lamina cribrosa that provides resiliency and deformability to the tissue. The elastic properties of the lamina cribrosa are important to buffer the constant fluctuations in IOP. Elastic fibers in the lamina cribrosa must undergo constant stretch and relaxation cycles in response to daily, normal variations in IOP.33 A recent report using a finite element theoretical model of the human ONH indicate that the IOP-related stress applied to the lamina cribrosa is substantial even at low levels of IOP.34 In human glaucomatous optic neuropathy, astrocytes express elastin mRNA and synthesize abnormal elastic fibers leading to elastotic degeneration of the ECM and loss of resiliency and deformability, most likely in response to elevated IOP.6 7 8 9 Recent studies on cultured astrocytes of the human lamina cribrosa demonstrate that gene expression and synthesis of elastin is increased when astrocytes are exposed to increased hydrostatic pressure, providing evidence that mechanical stress is involved in the regulation of elastin synthesis by laminar astrocytes.35
Elastotic degeneration of the lamina cribrosa has been shown in human POAG and in glaucoma associated with pseudoexfoliation (PEX).7 9 10 Elastosis is characterized by increased deposition of elastin and elastin-associated microfibrils, which do not organize into typical elastic fibers but form large bizarre aggregates of disorganized matrix that label with elastin antibodies.36 37 38 In monkeys with experimental glaucoma, large confluent elastic fiber aggregates were observed in the ECM of the lamina cribrosa with characteristics similar to the elastotic fibers present in the human glaucomatous lamina. Moreover, similar to the observations in human glaucoma, the area of the ECM occupied by elastin-labeled material was significantly increased in eyes with experimental glaucoma when compared with the contralateral untreated eyes and to the eyes with optic nerve transection.
The increase in the amount of immunogold-labeled elastin material in the ECM of eyes with experimental glaucoma indicates that elastotic fibers may consist of newly synthesized elastin that does not organize into normal elastic fibers. Activation of tropoelastin mRNA expression indicates new synthesis of elastin.39 Previous studies in human glaucoma have demonstrated increased tropoelastin mRNA levels in the lamina cribrosa.6 8 In the present study, elastin mRNA was detected in eyes with glaucoma and not in contralateral controls or in eyes with optic nerve transection by ISH, further indicating that the increase in deposition of elastin is due to new synthesis, most likely in response to elevated IOP. In comparison, in eyes with transected optic nerves, elastin mRNA was detected in fibroblasts in the pia mater at the site of transection but not in the lamina cribrosa in the optic nerve head. New synthesis of elastin and other ECM proteins occur normally in wound healing of connective tissues in response to inflammatory mediators released at the site of injury.40 These factors released distally to the lamina cribrosa, at the site of transection, did not stimulate synthesis of elastin in nearby optic nerve astrocytes, strongly supporting the concept that astrocytes of the lamina cribrosa are uniquely specialized to synthesize elastin.
Synthesis of elastin by astrocytes in situ and in vitro has not been reported in other regions of the normal central nervous system (CNS). In the lamina cribrosa, synthesis of elastin by astrocytes most likely represents a specialization of these cells to the mechanical function of the tissue. Recent reports indicate that several astrocytomas, the most common form of primary brain tumors, express elastin and elastin binding protein (EBP) in vivo and in vitro.41 42 43 These studies strongly suggest that synthesis and degradation of elastin may play a role in cell adhesion for migration and in the regulation of proliferation of the tumor cells. To date, there is no evidence of type 1B astrocyte proliferation or elastolytic activity in glaucoma; however, optic nerve head astrocytes become reactive in both human and in experimental glaucoma in monkey and rat (reviewed in Ref. 9 ). Reactive astrocytes migrate out of the lamina cribrosa into the nerve bundles in glaucoma.44 Increased synthesis of soluble tropoelastin by astrocytes in response to elevated IOP may play a role in cell adhesion and migration of astrocytes in glaucoma by providing a substrate for attachment. Perhaps tropoelastin secretion is involved in the transition from quiescent to reactive astrocytes in glaucoma.
Mechanical stress can regulate expression of a variety of ECM genes, growth factors, cell adhesion molecules etc. (reviewed in Refs. 45 46 ). Astrocytes are attached to the ECM and to neighboring astrocytes by cell surface adhesion molecules, which are connected, to the cytoskeleton. Thus, changes in the ECM can be transmitted intracellularly through activation of ion channels or other membrane components.45 Because the cortical cytoskeleton is coupled to cell adhesion molecules, to membrane-bound enzymes, and to ion channels, biomechanical stress will cause intracellular responses in astrocytes (reviewed in Refs. 45 46 47 48 49 ). It is unknown how elastin connects with the cell membrane, but cell surface adhesion molecules or other binding proteins may bind elastin or elastin-associated microfibrils to the surface of astrocytes. In astrocytoma, elastin is bound to the cell surface by EBP, a 67-kDa nonintegrin receptor.43 It is possible that through cell surface adhesion molecules, EBP, or other unidentified receptors, the extracellular signal generated by pressure-induced mechanical stress is transmitted intracellularly to stimulate elastin synthesis.
Synthesis of growth factors, cytokines, and other cellular mediators by astrocytes in response to abnormally elevated IOP may also stimulate elastin synthesis in vivo. Members of the TGF-ß family of growth factors modulate tissue remodeling by upregulating synthesis of most ECM proteins, including elastin, collagen, fibronectin, and proteoglycans, and by decreasing the production of ECM-degradative enzymes.50 Of particular interest to the glaucomatous optic nerve head is TGF-ß2, known to upregulate elastin synthesis in many organs and diseases.51 52 Previous work in our laboratory found that TGF-ß2 is synthesized locally by the astrocytes and that TGF-ß2 is released in large amounts in the glaucomatous optic nerve head.53 TGF-ß1 and TGF-ß2 control elastin expression in mature tissues at the posttranscriptional level by allowing steady state levels of elastin mRNA to build up and protein production to occur.54 Thus, accumulation of abnormal elastin in response to elevated IOP in the lamina cribrosa may be due at least in part to release of TGF-ß2. Recently, the abnormal accumulation of ECM in experimental diabetic nephropathy, a hallmark of the disease, was suppressed by anti-TGF-ß antibody therapy.55 One can speculate that interfering locally with TGF-ß2 may prevent the extensive remodeling of the ECM in glaucoma.
In conclusion, glaucomatous optic neuropathy is a chronic disease that spans decades, in which structural changes in the ECM and loss of resiliency and compliance may occur throughout the disease process and contribute to its progression. Increased expression of abnormal elastin and elastosis may persist after the pressure is lowered, permanently changing the biomechanical properties of the tissue and increasing susceptibility to further damage, even at lower levels of IOP-related stress. Although there are many differences between the primate model of experimental glaucoma reported here and human glaucoma, the results of this study coupled with our recent observations in vitro indicate that optic nerve head astrocytes are mechanosensitive cells. Astrocytes of the lamina cribrosa respond to the stress generated by elevated IOP in a manner similar to that in human glaucoma. In contrast, the acute loss of axons that occurs in transection neither elicits responses in astrocytes of the optic nerve head nor alters the structure of the tissues. This evidence strongly suggests that abnormally elevated IOP or perhaps even IOP within generally normal levels in the presence of other susceptibility factors predisposing to increased expression of abnormal elastin and elastosis (e.g., decreased vascular perfusion or PEX) and perhaps race or unknown genetic factors are indeed a major factors in the development of the neuropathy. In addition, our results further indicate that the site of injury to the axons of the retinal ganglion cells is at the level of the optic nerve head.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication September 20, 2000; revised January 8, 2001, and April 25, 2001; accepted June 7, 2001.
Commercial relationships policy: N.
The publication costs of this article were defrayed in part by page
charge payment. This article must therefore be marked
"advertisement" in accordance with 18 U.S.C.
1734
solely to indicate this fact.
Corresponding author: M. Rosario Hernandez, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine, 660 S. Euclid Avenue, Box 8096, St. Louis, MO 63110. hernandez{at}vision.wustl.edu
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Mandal, M. Shahidullah, N. A. Delamere, and M. A. Teran Elevated hydrostatic pressure activates sodium/hydrogen exchanger-1 in rat optic nerve head astrocytes Am J Physiol Cell Physiol, July 1, 2009; 297(1): C111 - C120. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kwon, J. H. Fingert, M. H. Kuehn, and W. L.M. Alward Primary Open-Angle Glaucoma N. Engl. J. Med., March 12, 2009; 360(11): 1113 - 1124. [Full Text] [PDF] |
||||
![]() |
J. F Schmidt, O. A Agapova, P. Yang, P. L Kaufman, and M R. Hernandez Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy Br. J. Ophthalmol., September 1, 2007; 91(9): 1219 - 1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Johnson, L. Jia, W. O. Cepurna, T. A. Doser, and J. C. Morrison Global Changes in Optic Nerve Head Gene Expression after Exposure to Elevated Intraocular Pressure in a Rat Glaucoma Model Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3161 - 3177. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Urban, O. Agapova, V. Hucthagowder, P. Yang, B. C. Starcher, and M. R. Hernandez Population Differences in Elastin Maturation in Optic Nerve Head Tissue and Astrocytes Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3209 - 3215. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Bhattacharya, J. S. Crabb, V. L. Bonilha, X. Gu, H. Takahara, and J. W. Crabb Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2508 - 2514. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Guo, V Tsatourian, V Luong, A G Podolean, D A Jackson, F W Fitzke, and M F Cordeiro En face optical coherence tomography: a new method to analyse structural changes of the optic nerve head in rat glaucoma Br. J. Ophthalmol., September 1, 2005; 89(9): 1210 - 1216. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Spoerl, A. G. Boehm, and L. E. Pillunat The Influence of Various Substances on the Biomechanical Behavior of Lamina Cribrosa and Peripapillary Sclera Invest. Ophthalmol. Vis. Sci., April 1, 2005; 46(4): 1286 - 1290. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Downs, J-K. F. Suh, K. A. Thomas, A. J. Bellezza, R. T. Hart, and C. F. Burgoyne Viscoelastic Material Properties of the Peripapillary Sclera in Normal and Early-Glaucoma Monkey Eyes Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 540 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wamsley, B. T. Gabelt, D. B. Dahl, G. L. Case, R. W. Sherwood, C. A. May, M. R. Hernandez, and P. L. Kaufman Vitreous Glutamate Concentration and Axon Loss in Monkeys With Experimental Glaucoma Arch Ophthalmol, January 1, 2005; 123(1): 64 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ahmed, K. M. Brown, D. A. Stephan, J. C. Morrison, E. C. Johnson, and S. I. Tomarev Microarray Analysis of Changes in mRNA Levels in the Rat Retina after Experimental Elevation of Intraocular Pressure Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1247 - 1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Levin, R. Ritch, J. E. Richards, and T. Borras Stem Cell Therapy for Ocular Disorders Arch Ophthalmol, April 1, 2004; 122(4): 621 - 627. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Chauhan, T. L. LeVatte, C. A. Jollimore, P. K. Yu, H. A. Reitsamer, M. E. M. Kelly, D.-Y. Yu, F. Tremblay, and M. L. Archibald Model of Endothelin-1-Induced Chronic Optic Neuropathy in Rat Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 144 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Grozdanic, D. M. Betts, D. S. Sakaguchi, R. A. Allbaugh, Y. H. Kwon, and R. H. Kardon Laser-Induced Mouse Model of Chronic Ocular Hypertension Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4337 - 4346. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Chauhan, J. Pan, M. L. Archibald, T. L. LeVatte, M. E. M. Kelly, and F. Tremblay Effect of Intraocular Pressure on Optic Disc Topography, Electroretinography, and Axonal Loss in a Chronic Pressure-Induced Rat Model of Optic Nerve Damage Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2969 - 2976. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |